Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00559390
Other study ID # 0956-023
Secondary ID R01DK040605DK734
Status Completed
Phase N/A
First received November 15, 2007
Last updated April 3, 2013
Start date July 2006
Est. completion date October 2012

Study information

Verified date April 2013
Source Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardUnited States: Federal Government
Study type Observational

Clinical Trial Summary

In this study, we want to find out more about polycystic ovary syndrome(PCOS). This is a common problem in about 7% of teenage girls. Problems may include irregular periods, extra hair on the face, chest and back areas. It seems that PCOS is related to a high level of male hormones and to another problem called metabolic syndrome(MBS). People with MBS may have high blood pressure, low good cholesterol, high blood fats and extra fat around the waist. Girls with MBS are at high risk for getting diabetes and heart disease.


Description:

Once enrolled in the study, you will have a physical exam done. This includes getting a medical history, height, weight, blood pressure and heart rate. We will also listen to your heart and lungs. We will also look at your skin and determine what stage of puberty you are in by looking at your breast growth and body hair. You will also have two (maybe three) blood tests. The first one is an oral glucose tolerance test (OGTT). During this test, we will have you drink an orange sugary drink and then we will draw your blood. The second test is a frequently sampled intravenous glucose tolerance test (FSIGT). During this test, we will give you insulin through one IV catheter and then we will draw blood from another IV catheter. The third test that you might have done is an ACTH test. During this test, we will draw your blood and then you will be given a dose of cortrosyn (a hormone that your body already makes) and then we will draw your blood again. You will also have two scans of your body done during your visit. There will be a Dual Energy X-Ray Scan (DEXA) and a Magnetic Resonance Imaging Scan (MRI). You will be placed in the machines and then the scanner will move over your body.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 8 Years to 12 Years
Eligibility Inclusion Criteria:

- Relatives with polycystic ovary syndrome

- No relatives with polycystic ovary syndrome

- Overweight

- White non-hispanic girls

Exclusion Criteria:

- Chronic Illness

- Smokers

- Already having periods

Study Design

Observational Model: Family-Based, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Northwestern University Chicago Illinois

Sponsors (4)

Lead Sponsor Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Ann & Robert H Lurie Children's Hospital of Chicago, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Northwestern Memorial Hospital

Country where clinical trial is conducted

United States, 

References & Publications (1)

Urbanek M, Sam S, Legro RS, Dunaif A. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab. 2007 Nov;92(11):4191-8. Epub 2007 Sep 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary It is believed that PCOS is inherited. We are trying to look for clinical, blood and/or genetic markers of PCOS in the sisters and daughters of women with PCOS age 8 until onset of menses No